Pharmaceutical Preparations
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| RA Capital Management, L.P. | 12.23M | $21.0M | 28.54% | +3.89M | 2026-06-30 |
| Sands Capital Alternatives, LLC | 2.29M | $4.0M | 5.34% | +166.7K | 2026-06-30 |
| Vanguard Capital Management LLC | 952.0K | $1.0M | 2.22% | +230.0K | 2026-06-30 |
| Wellington Management Group LLP | 888.1K | $1.0M | 2.07% | -- | 2026-06-30 |
| Renaissance Technologies LLC | 758.9K | $1.0M | 1.77% | +423 | 2026-06-30 |
| Two Sigma Investments, LP | 641.5K | $1.0M | 1.50% | -- | 2026-06-30 |
| Marshall Wace, LLP | 531.9K | -- | 1.24% | -28.6K | 2026-06-30 |
| Bridgeway Capital Management, LLC | 378.9K | -- | 0.88% | +220.0K | 2026-06-30 |
| Geode Capital Management, LLC | 265.2K | -- | 0.62% | +28.9K | 2026-06-30 |
| BlackRock, Inc. | 239.1K | -- | 0.56% | +30.2K | 2026-06-30 |
